Treatment for Age-Related Macular Degeneration (AMD): Options, Medications & Outlook
Evidence-based Age-Related Macular Degeneration (AMD) treatment: first-line medications, monitoring targets, escalation criteria, and long-term clinical outlook.
Updated March 27, 2026
Treatment for Age-Related Macular Degeneration (AMD) focuses on symptom control, prevention of complications, and quality-of-life improvement. AMD causes central vision loss in people over 50 due to deterioration of the macula. Dry AMD is more common; wet AMD progresses faster and responds to anti-VEGF injections. Antioxidant supplements slow progression in intermediate AMD.
Clinical Context
The primary approach involves condition-specific pharmacological and non-pharmacological therapy guided by clinical guidelines. Monitoring typically includes condition-specific biomarkers and clinical assessment at scheduled review. Treatment intensity is tailored to disease severity, patient comorbidities, and response. Guideline-directed therapy reduces the risk of complications, hospitalisation, and disease progression.
Clinical Pathway
Age-Related Macular Degeneration (AMD) — Full Condition GuideCondition HubAge-Related Macular Degeneration (AMD) — Treatment PathwaysTreatmentAge-Related Macular Degeneration (AMD) — Prognosis & OutlookPrognosisAge-Related Macular Degeneration (AMD) — Differential DiagnosisDifferentialFrequently Asked Questions
Treatment for Age-Related Macular Degeneration (AMD): Options, Medications & Outlook?+
Treatment for Age-Related Macular Degeneration (AMD) focuses on symptom control, prevention of complications, and quality-of-life improvement. AMD causes central vision loss in people over 50 due to deterioration of the macula. Dry AMD is more common; wet AMD progresses faster and responds to anti-VEGF injections. Antioxidant supplements slow progression in intermediate AMD.
What is the first-line treatment for Age-Related Macular Degeneration (AMD)?+
First-line treatment typically involves condition-specific pharmacological and non-pharmacological therapy guided by clinical guidelines. The specific agent and dose are tailored to your presentation and clinical profile.
How long does treatment for Age-Related Macular Degeneration (AMD) last?+
Some conditions require short-term treatment (acute infections, self-limiting disorders). Many chronic conditions require indefinite treatment to maintain disease control and prevent relapse.
What happens if Age-Related Macular Degeneration (AMD) is not treated?+
Untreated Age-Related Macular Degeneration (AMD) can progress, increasing the risk of complications and organ damage. Early treatment generally leads to better outcomes and reduced long-term burden.
Our AI Symptom Checker analyzes your symptoms and suggests possible conditions based on clinical guidelines.
Start Free Analysis →